Picture of Zura Bio logo

ZURA — Zura Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Zura Bio Ltd expected to post a loss of 15 cents a share - Earnings Preview

* Zura Bio Ltd  ZURA.OQ   ZURA.O  is expected to show no
change in
quarterly revenue when it reports  results on August 12
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Zura Bio Ltd is for a
loss
of 15 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Zura Bio
Ltd is
$16.00​, above​ its last closing price of $3.54. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001               -0.23      -0.02     Beat    91.4
 Dec. 31 0001              -0.23      -0.19     Beat    17.5
 Jan. 1 0001   -0.25       -0.25      -0.18     Beat    27.4​
 Jun. 30 2023  -0.23       -0.25      -1.31     Missed  -431.1
 ​​                                                     
                                                        ​
 This summary was machine generated August 9 at 18:54 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Zura Bio

See all news